| RS119103223 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS119103224 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS119103225 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS119103226 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS119103227 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS119103228 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS119103229 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS119103230 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS119103231 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS119103232 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, BTD-related disorder |
| RS119103233 |
SEC63
|
Health Risk |
Pathogenic |
Polycystic liver disease 2, Polycystic liver disease 2 |
| RS119103234 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Gnathodiaphyseal dysplasia |
| RS119103236 |
ALG3
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS119103238 |
ALG3
|
Health Risk |
Pathogenic |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS119103240 |
DLAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E2 deficiency, Pyruvate dehydrogenase E2 deficiency |
| RS119103241 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS119103242 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS119103243 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS119103244 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS119103245 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS119103248 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS119103249 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS119103251 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS119103252 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS119103253 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS119103254 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS119103255 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS119103256 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS119103257 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS119103258 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS119103259 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS119103260 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS119103261 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2A2, Charcot-Marie-Tooth disease type 2 |
| RS119103262 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2A2, Charcot-Marie-Tooth disease |
| RS119103263 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2A2, Hereditary motor and sensory neuropathy with optic atrophy |
| RS119103264 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease type 2A2 |
| RS119103265 |
MFN2
|
Health Risk |
Pathogenic |
Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease type 2A2 |
| RS119103266 |
MFN2
|
Health Risk |
Pathogenic |
Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease |
| RS119103267 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, axonal |
| RS119103268 |
MFN2
|
Health Risk |
Pathogenic |
Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease type 2A2 |
| RS119103269 |
CYBA
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS119103270 |
NCF1
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS119103271 |
NCF1
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS119103272 |
NCF1
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS119103273 |
NCF1
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS119103274 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS119103276 |
NCF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS119103277 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Von Hippel-Lindau syndrome |
| RS119103278 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Von Hippel-Lindau syndrome |
| RS119103279 |
MYH14
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 4A, Autosomal dominant nonsyndromic hearing loss 4A |
| RS119103280 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome |
| RS119103281 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, MYH14-related disorder |
| RS119103283 |
CYP4V2
|
Health Risk |
Pathogenic |
Bietti crystalline corneoretinal dystrophy, Retinal dystrophy |
| RS119103284 |
CYP4V2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bietti crystalline corneoretinal dystrophy, Bietti crystalline corneoretinal dystrophy |
| RS119103285 |
CYP4V2
|
Health Risk |
Pathogenic |
Bietti crystalline corneoretinal dystrophy, Bietti crystalline corneoretinal dystrophy |
| RS119103286 |
TTC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 8, Bardet-Biedl syndrome |
| RS119103287 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Exostoses |
| RS119103288 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Exostoses |
| RS119103289 |
EXT1
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS119103290 |
EXT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital exostosis, Exostoses |
| RS1191043398 |
INPP5E
|
Health Risk |
Pathogenic |
Joubert syndrome, INPP5E-related disorder |
| RS1191046309 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopetrosis, Osteopetrosis |
| RS1191056306 |
EGLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS1191056931 |
WDR19
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Senior-Loken syndrome 8 |
| RS1191074716 |
SLC4A11
|
Health Risk |
Pathogenic |
Corneal dystrophy-perceptive deafness syndrome, Corneal dystrophy |
| RS1191085308 |
TAOK1
|
Health Risk |
Likely pathogenic |
— |
| RS1191090323 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS1191093439 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Arrhythmogenic right ventricular dysplasia 11 |
| RS1191111879 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1191117776 |
CD46
|
Health Risk |
Pathogenic/Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome |
| RS1191124879 |
MPLKIP
|
Health Risk |
Pathogenic |
— |
| RS1191141117 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS1191141364 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS1191142951 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 10 |
| RS1191143782 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Age related macular degeneration 2 |
| RS1191147473 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS1191157047 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1J |
| RS1191193699 |
MVK
|
Health Risk |
Pathogenic |
Porokeratosis 3, disseminated superficial actinic type |
| RS1191198388 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1191203668 |
DNMT3B
|
Health Risk |
Likely pathogenic |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS1191211949 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, Myopathy |
| RS1191230933 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS1191238988 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS1191239079 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS1191259480 |
RDX
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 24, Autosomal recessive nonsyndromic hearing loss 24 |
| RS1191270963 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1191280597 |
TCTN2
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1191286670 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS1191287768 |
TNRC6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Global developmental delay with speech and behavioral abnormalities |
| RS1191310144 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1191322448 |
CDH3
|
Health Risk |
Conflicting classifications of pathogenicity |
EEM syndrome, EEM syndrome |
| RS1191340189 |
TCF12
|
Health Risk |
Conflicting classifications of pathogenicity |
TCF12-related craniosynostosis, Hypogonadotropic hypogonadism 26 with or without anosmia |
| RS1191346899 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS1191352284 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1191355416 |
MCCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS1191361764 |
CYBA
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS1191391104 |
POMT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1191402804 |
CYP11B2
|
Health Risk |
Pathogenic |
Corticosterone methyloxidase type 2 deficiency, Corticosterone methyloxidase type 2 deficiency |
| RS1191415115 |
AP4M1
|
Health Risk |
Pathogenic |
— |
| RS1191429915 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy |